STUDI PENGGUNAAN ANTIPLATELET PADA PASIEN GAGAL JANTUNG DI RSUD R.T NOTOPURO SIDOARJO

Background: Heart failure is a complex clinical syndrome, heart failure can becaused by disturbances in myocardial function systolic and diastolic function, valvular and pericardial disease, and several conditions. systolic and diastolic function, valvular or pericardial disease, and some circumstances that can cause
impaired blood flow such as fluid retention. can cause disturbances in blood flow such as fluid retention. The use of antiplatelets as adjunctive therapy is given to prevent other cardiovascular events that can be caused by thrombus formation such as atherosclerosis. Antiplatelets are a class of drugs used for the treatment of
thrombotic diseases such as (AMI) acute myocardial infarction, (ACS) acute coronary syndrome, (PCI) percutaneous coronary intervention, cardiac surgery, as primary and secondary prevention of cardiovascular disease.
Objective: Describe the pattern of antiplatelet use in heart failure including type, dose, route, frequency and duration of use at RSUD R.T Notopuro Sidoarjo.
Methods: Observational and descriptive methods, with retrospective and descriptive data collection to describe the pattern of antiplatelet use.
Results and Conclusion: The single use pattern was 49 patterns (50%), combination 2 was 30 patterns (31)%, combination 3 was 3 patterns (3%). The most common single-use pattern was clopidogrel (1x75mg) po with 37 patterns (76%), combination 2 acetosal (1x80mg) po + clopidogrel (1x75mg) po with 28 patterns (93%), combination 3 acetosal (1x80mg) po + clopidogrel (1x75mg) po + ticagrelor (2x90mg) po with 3 patterns (100%). There were 11 switch patterns.